glp-1 and general anesthesia Are Serious Risks of Semaglutide Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia ASA Advises No Longer Holding

Ready to experience the glow for yourself

Physicians and patients have to just look at all the data and make a decision about treatment together, she said

We update protocols when new clinical trial data publishes (for example, when TRIUMPH Phase 3 readouts update the retatrutide protocol), when regulatory status changes (the February 2026 FDA Category 2 reclassification affected multiple compound pages), or when reconstitution math needs correction

This approach reduces formulation complexity and cost, while also contributing to the development of products with improved purity and health profiles

A 2025 study evaluating patients with diabetes found that those using GLP-1 drugs may be at a lower risk of developing Alzheimers disease and other types of dementia

M.JensenM.et al